Diurnal patterns of soluble amyloid precursor protein metabolites in the human central nervous system.
about
Preanalytical Confounding Factors in the Analysis of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: The Issue of Diurnal VariationBody fluid biomarkers in Alzheimer's diseaseDiurnal oscillation of CSF Aβ and other AD biomarkers.CNS amyloid-β, soluble APP-α and -β kinetics during BACE inhibition.No diurnal variation of classical and candidate biomarkers of Alzheimer's disease in CSF.The effects of different familial Alzheimer's disease mutations on APP processing in vivo.Associations Between β-Amyloid Kinetics and the β-Amyloid Diurnal Pattern in the Central Nervous System.Does sleep disturbance affect the amyloid clearance mechanisms in Alzheimer's disease?Viral gene transfer of APPsα rescues synaptic failure in an Alzheimer's disease mouse model.Amyloid-β Protein Precursor Cleavage Products in Postmortem Ventricular Cerebrospinal Fluid of Alzheimer's Disease Patients.Re-evaluation of soluble APP-α and APP-β in cerebrospinal fluid as potential biomarkers for early diagnosis of dementia disorders.Understanding the roles of mutations in the amyloid precursor protein in Alzheimer disease.Effect of sleep on overnight CSF amyloid-β kinetics.Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.Acute function of secreted amyloid precursor protein fragment APPsα in synaptic plasticity.Systems Pharmacology Analysis of the Amyloid Cascade after β-Secretase Inhibition Enables the Identification of an Aβ42 Oligomer Pool.Distinct in vivo roles of secreted APP ectodomain variants APPsα and APPsβ in regulation of spine density, synaptic plasticity, and cognition.
P2860
Q26801663-21B4A2B1-9B1E-4E21-A0F1-26B21E54620CQ26830098-956F1A66-C810-41C6-9446-8A99CCF1FCE1Q33647053-5503A3B7-9DA6-44FB-8607-0C3327CF40DAQ33735544-DB7C5ACD-B678-4A83-B4CA-6EB439C5B514Q37237233-DFEE71C0-CA4C-4EB2-BC98-90B9EF3C39FBQ37645358-30956F83-8783-4391-B8C0-D90A215CA821Q38780800-B82F0535-8A20-496A-924F-00080F87C018Q39317466-7558192B-7BC7-4F37-BAB4-9F1FC1933C9DQ40354888-F4A6F796-FB8E-48F0-A59D-02840D707657Q41325973-01AAAEAC-C755-4322-A526-5B7A991535BDQ42118491-02DD3C15-3113-4FD7-B7DA-0D9820D5F863Q47431150-FA0028CC-4CBB-47EE-8399-5C006F032B8FQ47563259-DA586AB8-A796-4900-B239-B2AA9EAA7173Q47587631-62D70D94-E4FB-4521-A1BE-8DA9B86BA8DBQ48444707-76C11F8D-750C-4205-B8FC-6F1702A95F28Q48940844-92E103A8-316D-4461-A2F8-2E28D0F19308Q54234721-19245AD9-0C86-4B49-A978-013E9C9CA360
P2860
Diurnal patterns of soluble amyloid precursor protein metabolites in the human central nervous system.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Diurnal patterns of soluble am ...... human central nervous system.
@ast
Diurnal patterns of soluble am ...... human central nervous system.
@en
type
label
Diurnal patterns of soluble am ...... human central nervous system.
@ast
Diurnal patterns of soluble am ...... human central nervous system.
@en
prefLabel
Diurnal patterns of soluble am ...... human central nervous system.
@ast
Diurnal patterns of soluble am ...... human central nervous system.
@en
P2093
P2860
P50
P1433
P1476
Diurnal patterns of soluble am ...... human central nervous system.
@en
P2093
Tammie L S Benzinger
Tom Kasten
Vitaliy Ovod
Wendy Sigurdson
Yafei Huang
P2860
P304
P356
10.1371/JOURNAL.PONE.0089998
P407
P577
2014-03-19T00:00:00Z